Importation
Prime Minister Trudeau Promises to Protect the Canadian Drug Supply In The Face Of The U.S. Drug Importation Statement
Canadian Prime Minister Justin Trudeau was interviewed today in Iqaluit, and according to CBC Canada, he reassured Canadians that Health Canada is already safeguarding the Canadian prescription drug supply regardless of international pressure.
[...]Partnership for Safe Medicines Statement on Reckless and Politically-Motivated Federal Drug Importation Proposal
Partnership for Safe Medicines Statement on Reckless and Politically-Motivated Drug Importation Proposal Washington, D.C. (July 31, 2019) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to today’s announcement by HHS Secretary Alex Azar and FDA Commissioner Ned Sharpless: “Less than a year and a half ago,…
[...]ASOP Canada and 14 Other Canadian Patient Organizations Raise Alarm with Canadian Minister of Health on U.S. Drug Importation Proposals
The Canadian branch of the Alliance for Safe Online Pharmacies (ASOP), along with fourteen other Canadian patient advocacy organizations have written a letter to Canadian Health Minister, the Honorable Ginette Petitpas Taylor imploring her to prevent the United States from wiping out the Canadian prescription medication supply with their misguided importation proposals.
[...]Things we learned from sending a Freedom of Information Act request to Florida’s healthcare agency implementing importation
PSM filed comments recently with the state of Florida’s healthcare agency that’s attempting to make the mess of Canadian drug importation work after the legislature passed it without any serious scrutiny. After we filed comments, we subsequently filed a request to see who else filed comments and we’re left now with more questions than answers.…
[...]Medical Device King Exec Takes a Plea Deal Instead of a Retrial; Gets 32 Months in Prison
New York-based Pharmalogical, Inc. (d/b/a Medical Device King and Taranis Medical Corp.) grossed $17 million by misleading U.S. medical practices into believing they were buying FDA-approved products rather than “unapproved products imported through a series of unidentified middlemen in Turkey and elsewhere.” President William Scully, was convicted of these activities in 2015, but the conviction was vacated in 2017. In 2018, he pleaded guilty, and was sentenced to 32 months in prison.
[...]New Analysis by HDA Finds Importation Proposals Are Too Expensive and Pose Health Risks to Patients
A report just released the HDA Research Foundation demonstrates that federal importation proposals to allow drug importation are devoid of practical implementation guidance and funding, so will fail to guarantee federal safety and quality standards for prescription medication.
[...]Drug Distribution Experts Warn That State Plans To Import Foreign Drugs Will Undermine Safety
This editorial by Adam Fein and Dirk Rodgers was published in Stat News on July 11, 2019. In it, Fein and Rodgers warn that plans by states to create drug importation programs will open new pathways for counterfeit drugs to enter the U.S. drug supply chain…
[...]Importation Is An Opportunity For Organized Crime to Expand Counterfeit Drug Profits, DEA Veteran Says
This editorial by retired DEA agent Douglas Hebert was published in The Arizona Capital Times ,on June 27, 2019. In it, Hebert explains how drug importation programs will help organized crime expand their $200 billion-a-year counterfeit pharmaceutical industry into the U.S., at the expense of Americans.
[...]National Pharmacy Organizations Ask HHS Secretary Azar for Clarity on Drug Importation Proposals
On June 24, 2019, the National Alliance of State Pharmacy Associations (NASPA), along with the American Pharmacists Association (APhA), and the National Association of Chain Drug Stores (NACDS) wrote a joint letter to U.S. Health and Human Services (HSS) Secretary Alex Azar questioning the wisdom of poorly thought-out importation proposals.
[...]Retired Canadian law enforcement official urges the New York Legislature: “Step Away” from dangerous drug importation proposal
In this editorial, which was published in Crain’s New York Business on June 19, 2019, Canadian law enforcement veteran Don Bell explains that the New York Legislature’s effort to establish a wholesale prescription drug importation program, is “a gigantic loophole that criminals will pounce on to traffic counterfeit drugs into the state.”
[...]